Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 7/2019

01.04.2019 | Thoracic Oncology

Predictive Value of Body Mass Index for Short-Term Outcomes of Patients with Esophageal Cancer After Esophagectomy: A Meta-analysis

verfasst von: Peiyu Wang, MD, Yin Li, MD, PhD, Haibo Sun, MD, PhD, Shilei Liu, MD, Ruixiang Zhang, MD, PhD, Xianben Liu, MD, Zhengshuai Zhu, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The association between body mass index (BMI) and short-term outcomes after esophagectomy remains controversial.

Methods

A meticulous search for articles describing the association between BMI and perioperative outcomes after esophagectomy was conducted using PubMed, EMBASE, and the Cochrane Library. The study classified BMI according to the World Health Organization definitions and Asian-specific BMI cutoff values. Normal weight was selected as the comparator, and the odds ratio (OR) was calculated as the primary effect.

Results

This meta-analysis included 13 studies with 5480 patients. Obese patients exhibited higher risks of overall complication (OR 1.37; P = 0.013), anastomotic leakage (OR 1.74; P = 0.001), and thromboembolic complications (OR 2.05; P = 0.039). Subgroup analysis indicated that obese patients from Western countries had a higher risk of wound infection (OR 2.22; P = 0.022), whereas obese Asians were more likely to experience pulmonary complications (OR 1.64; P = 0.002). Overweight patients displayed no significant differences in major complications relative to normal-weight patients, except for the increased risk of overall complications (OR 1.32; P = 0.030). Additionally, underweight patients showed increased incidence of pulmonary complications (OR 1.92; P = 0.020 and anastomotic leakage (OR 1.64; P = 0.034). Morbid obesity also was analyzed separately with limited data, and this group displayed a higher risk of wound infection (OR 1.62; P = 0.027) and thromboembolic complications (OR 2.65; P = 0.003). No significant differences in mortality were observed among patients in different BMI categories.

Conclusions

Obesity and underweight statuses were confirmed risk factors for several complications after esophagectomy, whereas overweight patients tended to experience greater benefit from surgery.
Literatur
1.
Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–48.CrossRefPubMedCentral
2.
3.
Pasquali S, Yim G, Vohra RS, et al. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable esophageal carcinoma: a network meta-analysis. Ann Surg. 2017;265:481–91.CrossRefPubMed
4.
Low DE, Kuppusamy MK, Alderson D, et al. Benchmarking complications associated with esophagectomy. Ann Surg. 2019;269:291–8.CrossRefPubMed
5.
Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250:798–807.CrossRefPubMed
6.
Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.CrossRefPubMed
7.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005; 143:199–201.CrossRefPubMed
8.
Lagergren J, Bergström R, Nyrén O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999;130:883–90.CrossRefPubMed
9.
Kruhlikava I, Kirkegard J, Mortensen FV, Kjaer DW. Impact of body mass index on complications and survival after surgery for esophageal and gastro-esophageal-junction cancer. Scand J Surg. 2017;106:305–10.CrossRefPubMed
10.
Wightman SC, Posner MC, Patti MG, Ganai S, Watson S, Prachand V, Ferguson, MK. Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017;30:1–6.CrossRefPubMed
11.
Scarpa M, Cagol M, Bettini S, et al. Overweight patients operated on for cancer of the esophagus survive longer than normal-weight patients. J Gastrointest Surg. 2013;17:218–27.CrossRefPubMed
12.
Melis M, Weber J, Shridhar R, Hoffe S, Almhanna K, Karl RC, Meredith KL. Body mass index and perioperative complications after oesophagectomy for adenocarcinoma: a systematic database review. BMJ Open. 2013;3:e001336.CrossRefPubMedPubMedCentral
13.
Salem AI, Thau MR, Strom TJ, et al. Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center. Dis Esophagus. 2016;30:1–7.
14.
Shridhar R, Hayman T, Hoffe SE, et al. Body mass index and survival in esophageal adenocarcinoma treated with chemoradiotherapy followed by esophagectomy. J Gastrointest Surg. 2012;16:1296–302.CrossRefPubMed
15.
Blom RL, Lagarde SM, Klinkenbijl JH, Busch OR, van Berge Henegouwen MI. A high body mass index in esophageal cancer patients does not influence postoperative outcome or long-term survival. Ann Surg Oncol. 2012;19:766–71.CrossRefPubMed
16.
Watanabe M, Ishimoto T, Baba Y, Nagai Y, Yoshida N, Yamanaka T, Baba H. Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2013;20:3984–91.CrossRefPubMed
17.
Miao L, Chen H, Xiang J, Zhang Y. A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy. J Cancer Res Clin Oncol. 2014;141:941–50.CrossRefPubMed
18.
Hasegawa T, Kubo N, Ohira M, et al. Impact of body mass index on surgical outcomes after esophagectomy for patients with esophageal squamous cell carcinoma. J Gastrointest Surg. 2015;19:226–33.CrossRefPubMed
19.
Wu N, Zhu Y, Kadel D, Pang L, Chen G, Chen Z. The prognostic influence of body mass index, resting energy expenditure, and fasting blood glucose on postoperative patients with esophageal cancer. BMC Gastroenterol. 2016;16:142.CrossRefPubMedPubMedCentral
20.
Bhayani NH, Gupta A, Dunst CM, Kurian AA, Halpin VJ, Swanstrom LL. Does morbid obesity worsen outcomes after esophagectomy? Ann Thorac Surg. 2013;95:1756–61.CrossRefPubMed
21.
Scipione CN, Chang AC, Pickens A, Lau CL, Orringer MB. Transhiatal esophagectomy in the profoundly obese: implications and experience. Ann Thorac Surg. 2007;84:376–82 (discussion 383).CrossRefPubMed
22.
Kayani B, Okabayashi K, Ashrafian H, et al. Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis. World J Surg. 2012;36:1785–95.CrossRefPubMed
23.
24.
25.
Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer. 2013;109:2894–903.CrossRefPubMedPubMedCentral
26.
Park SK, Ryoo JH, Oh CM, et al. Effect of overweight and obesity (defined by Asian-specific cutoff criteria) on left ventricular diastolic function and structure in a general Korean population. Circ J. 2016;80:2489–95.CrossRefPubMed
27.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
28.
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313:1657–65.CrossRefPubMed
29.
30.
STARSurg Collaborative. Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery. Br J Surg. 2016;103:1157–72.
31.
31. Zogg CK, Mungo B, Lidor AO, Stem M, Rios Diaz AJ, Haider AH, Molena D. Influence of body mass index on outcomes after major resection for cancer. Surgery. 2015;158:472–85.CrossRefPubMed
32.
Ata A, Valerian BT, Lee EC, Bestle SL, Elmendorf SL, Stain SC. The effect of diabetes mellitus on surgical-site infections after colorectal and noncolorectalgeneral surgical operations. Am Surg. 2010;76:697–702.PubMed
33.
Okamura A, Watanabe M, Imamura Y, Kamiya S, Yamashita K, Kurogochi T, Mine S. Preoperative glycosylated hemoglobin levels predict anastomotic leak after esophagectomy with cervical esophagogastric anastomosis. World J Surg. 2017;41:200–7.CrossRefPubMed
34.
Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg Oncol. 2009;250:166–72.CrossRef
35.
American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140:1084–91.CrossRef
36.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290:66–72.CrossRefPubMed
37.
38.
Cheung KP, Taylor KR, Jameson JM. Immunomodulation at epithelial sites by obesity and metabolic disease. Immunol Res. 2012;52:182–99.CrossRefPubMed
39.
Rondina MT, Wheeler M, Rodgers GM, Draper L, Pendleton RC. Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients. Thromb Res. 2010;125:220–3.CrossRefPubMed
40.
Thomas DC, Arnold BN, Hoag JR, et al. Timing and risk factors associated with venous thromboembolism after lung cancer resection. Ann Thorac Surg. 2018;105:1469–75.CrossRefPubMed
41.
Kilic A, Schuchert MJ, Pennathur A, Yaeger K, Prasanna V, Luketich JD, Gilbert S. Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg. 2009;87:412–5.CrossRefPubMed
42.
Yoshida N, Watanabe M, Baba Y, et al. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today. 2014;44:526–32.CrossRefPubMed
43.
Bluman LG, Mosca L, Newman N, Simon DG. Preoperative smoking habits and postoperative pulmonary complications. Chest. 1998;113:883–9.CrossRefPubMed
44.
Van Daele E, Van de Putte D, Ceelen W, Van Nieuwenhove Y, Pattyn P. Risk factors and consequences of anastomotic leakage after Ivor Lewis oesophagectomydagger. Interact Cardiovasc Thorac Surg. 2016;22:32–7.CrossRefPubMed
45.
Baucom RB, Poulose BK, Herline AJ, Muldoon RL, Cone MM, Geiger TM. Smoking as dominant risk factor for anastomotic leak after left colon resection. Am J Surg. 2015;210:1–5.CrossRefPubMed
46.
Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay, and costs evaluated through a multivariate model analysis. Clin Nutr. 2003;22:235–9.CrossRefPubMed
47.
Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr. 2015;34:335–40.CrossRefPubMed
48.
Thomas MN, Kufeldt J, Kisser U, et al. Effects of malnutrition on complication rates, length of hospital stay, and revenue in elective surgical patients in the G-DRG-system. Nutrition. 2016;32:249–54.CrossRefPubMed
49.
Sun L, Quan XQ, Yu S. An epidemiological survey of cachexia in advanced cancer patients and analysis on its diagnostic and treatment status. Nutr Cancer. 2015;67:1056–62.CrossRefPubMed
50.
Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia, and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr. 2010;29:154–9.CrossRefPubMed
51.
Mesquita AF, Silva ECD, Eickemberg M, Roriz AKC, Barreto-Medeiros JM, Ramos LB. Factors associated with sarcopenia in institutionalized elderly. Nutr Hosp. 2017;34:345–51.CrossRefPubMed
52.
Harada K, Ida S, Baba Y, et al. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2016;29:627–33.CrossRefPubMed
53.
Ida S, Watanabe M, Yoshida N, et al. Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol. 2015;22:4432–7.CrossRefPubMed
54.
An X, Zhao Y, Zhang Y, Yang Q, Wang Y, Cheng W, Yang Z. Risk assessment of morbidly obese parturient in cesarean section delivery: a prospective, cohort, single-center study. Medicine Baltimore. 2017;96:e8265.CrossRefPubMedPubMedCentral
55.
De Jong A, Verzilli D, Geniez M, Chanques G, Nocca D, Jaber S. Why is the morbidly obese patient at high risk of anesthetic complications. Presse Med. 2018;47:453–63.CrossRefPubMed
56.
Carson JT, Shah SG, Ortega G, Thamyongkit S, Hasenboehler EA, Shafiq B. Complications of pelvic and acetabular fractures in 1331 morbidly obese patients (BMI ≥ 40): a retrospective observational study from the National Trauma Data Bank. Patient Saf Surg. 2018;12:26.CrossRefPubMedPubMedCentral
57.
Hopkins TJ, Raghunathan K, Barbeito A, et al. Associations between ASA physical status and postoperative mortality at 48 h: a contemporary dataset analysis compared to a historical cohort. Perioper Med London. 2016;5:29.CrossRef
58.
Ondeck NT, Bohl DD, Bovonratwet P, et al. Predicting adverse outcomes after total hip arthroplasty: a comparison of demographics, the American Society of Anesthesiologists class, the Modified Charlson Comorbidity Index, and the Modified Frailty Index. J Am Acad Orthop Surg. 2018;26:735-43.CrossRefPubMed
59.
Schlottmann F, Strassle PD, Patti MG. Transhiatal vs transthoracic esophagectomy: a NSQIP analysis of postoperative outcomes and risk factors for morbidity. J Gastrointest Surg. 2017;21:1757–63.CrossRefPubMed
60.
Fuentes E, Ahmad R, Hong TS, et al. The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality. J Surg Oncol. 2016;113:560–4.CrossRefPubMed
61.
Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, Mahattanobon S, Geater A. Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 2012;35:104–9.CrossRefPubMed
62.
Raymond DP, Seder CW, Wright CD, et al. Predictors of major morbidity or mortality after resection for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery database risk adjustment model. Ann Thorac Surg. 2016;102:207–14.CrossRefPubMedPubMedCentral
63.
Mayanagi S, Tsubosa Y, Omae K, et al. Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann Surg Oncol. 2017;24:3741–7.CrossRefPubMedPubMedCentral
64.
Thomson IG, Wallen MP, Hall A, et al. Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy. Int J Surg. 2018;53:86–92.CrossRefPubMed
65.
Sathornviriyapong S, Matsuda A, Miyashita M, et al. Impact of neoadjuvant chemoradiation on short-term outcomes for esophageal squamous cell carcinoma patients: a meta-analysis. Ann Surg Oncol. 2016;23:3632–40.CrossRefPubMed
66.
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.CrossRefPubMed
67.
Mungo B, Molena D, Stem M, et al. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality? Dis Esophagus. 2015;28:644–51.CrossRefPubMed
68.
Degisors S, Pasquer A, Renaud F, et al. Are thoracotomy and/or intrathoracic anastomosis still predictors of postoperative mortality after esophageal cancer surgery? A nationwide study. Ann Surg. 2017;266:854–62.CrossRefPubMed
69.
Hurewitz AN, Khan SU, Groth ML, Patrick PA, Brand DA. Dosing of unfractionated heparin in obese patients with venous thromboembolism. J Gen Intern Med. 2011;26:487–91.CrossRefPubMed
70.
Gockel I, Niebisch S, Ahlbrand CJ, et al. Risk and complication management in esophageal cancer surgery: a review of the literature. Thorac Cardiovasc Surg. 2016;64:596–605.CrossRefPubMed
71.
Pavia R, Barresi P, Piermanni V, Mondello B, Urgesi R. Role of artificial nutrition in patients undergoing surgery for esophageal cancer. Rays. 2006;31:25–9.PubMed
Metadaten
Titel
Predictive Value of Body Mass Index for Short-Term Outcomes of Patients with Esophageal Cancer After Esophagectomy: A Meta-analysis
verfasst von
Peiyu Wang, MD
Yin Li, MD, PhD
Haibo Sun, MD, PhD
Shilei Liu, MD
Ruixiang Zhang, MD, PhD
Xianben Liu, MD
Zhengshuai Zhu, MD
Publikationsdatum
01.04.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 7/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07331-w

Weitere Artikel der Ausgabe 7/2019

Annals of Surgical Oncology 7/2019 Zur Ausgabe

ASO Author Reflections

ASO Author Reflections: Surgical Treatment for Male Breast Cancer in the Modern Era

Pancreatic Tumors

Robotic Central Pancreatectomy for Well-Differentiated Neuroendocrine Tumor: Parenchymal-Sparing Procedure

Breast Oncology

Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast

Breast Oncology

Germline Genetic Testing: What the Breast Surgeon Needs to Know

Sarcoma

Defining Rupture in Gastrointestinal Stromal Tumor: Semantics and Prognostic Value

Gastrointestinal Oncology

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.